These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 7702782)

  • 1. Evaluation of the thrombogenecity of microvascular prosthesis by in vivo microscopy.
    Kim YB; Reisch HP; Serafin D; Klitzman B
    J Korean Med Sci; 1994 Oct; 9(5):357-61. PubMed ID: 7702782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin coating of vascular prostheses reduces thromboemboli.
    Ritter EF; Kim YB; Reischl HP; Serafin D; Rudner AM; Klitzman B
    Surgery; 1997 Nov; 122(5):888-92. PubMed ID: 9369888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silyl-heparin bonding improves the patency and in vivo thromboresistance of carbon-coated polytetrafluoroethylene vascular grafts.
    Laredo J; Xue L; Husak VA; Ellinger J; Singh G; Zamora PO; Greisler HP
    J Vasc Surg; 2004 May; 39(5):1059-65. PubMed ID: 15111862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin immobilization reduces thrombogenicity of small-caliber expanded polytetrafluoroethylene grafts.
    Heyligers JM; Verhagen HJ; Rotmans JI; Weeterings C; de Groot PG; Moll FL; Lisman T
    J Vasc Surg; 2006 Mar; 43(3):587-91. PubMed ID: 16520178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small-caliber heparin-coated ePTFE grafts reduce platelet deposition and neointimal hyperplasia in a baboon model.
    Lin PH; Chen C; Bush RL; Yao Q; Lumsden AB; Hanson SR
    J Vasc Surg; 2004 Jun; 39(6):1322-8. PubMed ID: 15192575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin bonding increases patency of long microvascular prostheses.
    Ritter EF; Fata MM; Rudner AM; Klitzman B
    Plast Reconstr Surg; 1998 Jan; 101(1):142-6. PubMed ID: 9427927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of platelet deposition and neointimal hyperplasia of heparin-coated small-caliber ePTFE grafts in a canine femoral artery bypass model.
    Lin PH; Bush RL; Yao Q; Lumsden AB; Chen C
    J Surg Res; 2004 May; 118(1):45-52. PubMed ID: 15093716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic bonding to polytetrafluoroethylene with tridodecylmethylammonium chloride.
    Harvey RA; Alcid DV; Greco RS
    Surgery; 1982 Sep; 92(3):504-12. PubMed ID: 7112401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative evaluation of ibuprofen treatment on thrombogenicity of expanded polytetrafluoroethylene vascular grafts.
    Gloviczki P; Hollier LH; Dewanjee MK; Trastek VF; Kopesky KR; Kaye MP
    Surgery; 1984 Feb; 95(2):160-8. PubMed ID: 6695334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of patency rate in heparin-coated small synthetic vascular grafts.
    Walpoth BH; Rogulenko R; Tikhvinskaia E; Gogolewski S; Schaffner T; Hess OM; Althaus U
    Circulation; 1998 Nov; 98(19 Suppl):II319-23; discussion II324. PubMed ID: 9852921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An alternative method for proximal placement of the heparin-coated tridodecylmethylammonium chloride (TDMAC) shunt.
    Wingard T; Donahoo JS; Williams GM
    Johns Hopkins Med J; 1979 Dec; 145(6):230-1. PubMed ID: 513430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patency of a small vessel prosthesis bonded to tissue plasminogen activator and iloprost.
    Greco RS; Kim HC; Donetz AP; Harvey RA
    Ann Vasc Surg; 1995 Mar; 9(2):140-5. PubMed ID: 7540408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of carbon coating and porosity on early patency of expanded polytetrafluoroethylene grafts: an experimental study.
    Akers DL; Du YH; Kempczinski RF
    J Vasc Surg; 1993 Jul; 18(1):10-5. PubMed ID: 8326650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of bacterial adherence to catheter surface with heparin.
    Ruggieri MR; Hanno PM; Levin RM
    J Urol; 1987 Aug; 138(2):423-6. PubMed ID: 3298698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized controlled trial comparing the safety and efficacy between the FUSION BIOLINE heparin-coated vascular graft and the standard expanded polytetrafluoroethylene graft for femoropopliteal bypass.
    Lumsden AB; Morrissey NJ;
    J Vasc Surg; 2015 Mar; 61(3):703-12.e1. PubMed ID: 25720929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapamycin-coated expanded polytetrafluoroethylene bypass grafts exhibit decreased anastomotic neointimal hyperplasia in a porcine model.
    Cagiannos C; Abul-Khoudoud OR; DeRijk W; Shell DH; Jennings LK; Tolley EA; Handorf CR; Fabian TC
    J Vasc Surg; 2005 Nov; 42(5):980-8. PubMed ID: 16275457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of in vitro endothelial cell adhesion to vascular graft material.
    Wigod MD; Klitzman B
    J Biomed Mater Res; 1993 Aug; 27(8):1057-62. PubMed ID: 8408118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel bioengineered small-caliber vascular graft incorporating heparin and sirolimus: excellent 6-month patency.
    Ishii Y; Sakamoto S; Kronengold RT; Virmani R; Rivera EA; Goldman SM; Prechtel EJ; Hill JG; Damiano RJ
    J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1237-45; discussion 1245-6. PubMed ID: 18544361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo platelet deposition on polytetrafluoroethylene coated with fibrin glue containing fibroblast growth factor 1 and heparin in a canine model.
    Gosselin C; Ren D; Ellinger J; Greisler HP
    Am J Surg; 1995 Aug; 170(2):126-30. PubMed ID: 7543261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A heparin-bonded vascular graft generates no systemic effect on markers of hemostasis activation or detectable heparin-induced thrombocytopenia-associated antibodies in humans.
    Heyligers JM; Lisman T; Verhagen HJ; Weeterings C; de Groot PG; Moll FL
    J Vasc Surg; 2008 Feb; 47(2):324-9; discussion 329. PubMed ID: 18241756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.